Persistent and Late-Onset Disseminated Intravascular Coagulation Are Closely Related to Poor Prognosis in Patients with Sepsis
- 23 October 2023
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 124 (05) , 399-407
Abstract
Background Septic-associated disseminated intravascular coagulation (DIC) is heterogeneous regarding prognosis and responsiveness to anticoagulant therapy. Objectives To investigate the relationship between the timing of development and recovery of DIC, its prognosis, and the difference in response to anticoagulant therapy in sepsis-associated DIC patients. Methods This study was performed with a dataset from a multicenter nationwide retrospective cohort study (J-Septic DIC registry) in Japan between 2011 and 2013 to reveal the subgroup “high risk of death in DIC” and investigate the relationship between anticoagulant use and mortality. Patients were assigned to four groups based on the International Society on Thrombosis and Haemostasis-overt DIC status at days 1 and 3: non-DIC (−/−), early-recovered DIC (+/−), late-onset DIC (−/+), and persistent DIC (+/+). Results A total of 1,922 patients were included. In-hospital mortality in persistent and late-onset DIC patients was significantly higher than in patients with non-DIC and early-recovered DIC. This finding indicates that persistent DIC and late-onset DIC were a poor-prognosis subgroup, “high-risk” DIC. Meanwhile, patients with high-risk DIC treated with anticoagulants had significantly better outcomes than those without anticoagulants after adjusting for confounding factors. Conclusion This study showed that individuals with a high risk of death, persistent DIC, and late-onset DIC were a poor-prognostic subgroup in septic DIC; however, high-risk DIC is also a subgroup that can obtain more benefits from anticoagulant therapy.Keywords
Funding Information
- JSTH research grant program (#2023–001)
- JSPS KAKENHI (#22K16630)
This publication has 24 references indexed in Scilit:
- Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trialsJournal of Thrombosis and Haemostasis, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulationThrombosis and Haemostasis, 2016
- Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shockCritical Care, 2015
- Epidemiology of severe sepsis in Japanese intensive care units: A prospective multicenter studyJournal of Infection and Chemotherapy, 2014
- Severe Sepsis and Septic ShockNew England Journal of Medicine, 2013
- Role of Fibrinolysis in SepsisSeminars in Thrombosis and Hemostasis, 2013
- The interactions between inflammation and coagulationBritish Journal of Haematology, 2005
- A META-ANALYSIS OF CONTROLLED TRIALS OF ANTICOAGULANT THERAPIES IN PATIENTS WITH SEPSISShock, 2003
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003